(Q52863110)
Statements
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer (English)
Johanna C Bendell
Konstanze Diefenbach
John Lettieri
Oliver Boix
A Craig Lockhart
Cindy O'Bryant
Kathleen N Moore
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference